04 / Policy · Analysis
Mitsui Chemicals agrees joint acquisition of JSR
Mitsui Chemicals agreed to acquire JSR jointly with the Development Bank of Japan, extending its semiconductor materials business from pellicles into photoresists, The Elec reported.

(Japan) Mitsui Chemicals’ board decided to acquire JSR shares jointly with the Development Bank of Japan (DBJ) in a ¥1.84 trillion transaction, The Elec reported.
(Japan) The Elec described Mitsui Chemicals as the leading pellicle supplier and JSR as the world’s second-largest photoresist supplier. It reported that the acquisition expands Mitsui Chemicals’ semiconductor materials business.
(Japan) According to The Elec, the transaction involves shares held by JIC Capital, part of Japan Investment Corporation (JIC). Mitsui Chemicals signed a share transfer agreement on the same day its board approved the joint acquisition.
From pellicles to photoresists
(Japan) The Elec explained that Mitsui Chemicals supplies pellicles, protective membranes for photomasks used in semiconductor lithography. These membranes protect the masks used to transfer circuit patterns.
(Japan) The Elec identified JSR as the world’s second-largest supplier of photoresists, light-sensitive materials used in lithography. The reported expansion therefore connects two types of materials used in the same manufacturing process.
The joint acquisition agreement
(Japan) According to The Elec, JIC Capital is the seller of the JSR shares. DBJ is Mitsui Chemicals’ partner in the joint acquisition.
(Japan) The Elec reported both a board decision and the signing of a share transfer agreement. Those steps establish the reported agreement to acquire the shares; completion remains a separate step.